Program Overview
The goal of this session is to help clinicians and other service providers understand the regional and national picture of HCV infection in the population of people who inject drugs. Treatment as prevention for HCV amongst PWID's is efficacious and cost-effective. As injecting drug use is the key driver of HCV incidence, the benefit of this approach is the rapid reduction in community HCV prevalence and incidence, achieved by treating a small proportion of current PWID's

Learning Objectives

At session completion, attendees should be able to:

Performance

-Increase HCV testing, diagnosis, counseling and treatment in PWID's

Competency

-Successful linkage to HCV care will increase. Providers will understand how to diagnose and treat HCV in the population

Increase Knowledge

-Understand the effectiveness and efficacy of HCV treatment for patients and the community

Curriculum

-Principles of harm reduction

-HCV screening recommendations

-Counseling to reduce risk of transmission

-Linkage to harm reduction services

-Linkage to substance use disorder treatment programs

-Treatment protocol

-Counseling to reduce risk of reinfection

-Post treatment testing